chronic pain - search results

Steph Sherer, Founder and President of Americans for Safe Access (ASA), discusses the prevalence, challenges and treatments for chronic pain management.

Pharma researchers Julie Blaising and Philip Smith from F. Hoffmann-La Roche Ltd. discuss the endocannabinoid system as a pathway to treat inflammatory diseases such as Inflammatory Bowel Disease (IBD) and endometriosis.

A staggering 51.6 million Americans live with pain daily; Ellen Smith from the U.S. Pain Foundation tells us about how medical cannabis supports her management of chronic pain.

Alberto Sainz Cort to discuss the prevalence of chronic pain and opioid use in the United States, as well as medical cannabis as a potential treatment for pain.

Norm Buckley and Jason Busse from the Michael G. DeGroote Institute for Pain Research and Care discuss prescribing practices, managing chronic pain with opioids, and the contribution of licit and illicit opioids towards the Canadian opioid crisis.

Dr Simon Erridge of Sapphire Medical Clinics discusses the therapeutic effects of medical cannabis for chronic pain, affecting 15.5 million people in England and why more evidence is needed to support greater patient access.

Norm Buckley and Jason Busse from the Michael G. DeGroote Institute for Pain Research & Care in Canada probe the effectiveness of opioid use in Canada as a treatment for chronic noncancer pain.

New research reveals how both alcohol consumption and withdrawal have the potential to result in hypersensitivity and increased chronic pain.

First in a series of five articles, Norm Buckley and Jason Busse explore the trials and tribulations associated with using opioids for chronic pain, particularly in Canada.

Cannabinoids with high THC-to-CBD ratios can help to improve moderate, short-term chronic pain band may be an alternative to opioids.

According to a UK study, those with multimorbidity are statistically between two and four times as likely to experience chronic pain.

A new study finds the exact molecular mechanism that turns acute pain into chronic pain - a condition that leads to the use of opioids and often, lifelong addiction.

Dr Ganesan Baranidharan, consultant in anaesthesia and pain medicine at the Leeds Teaching Hospitals NHS Trust, explains the power of neuromodulation for managing chronic pain and explains why comprehensive evidence is needed.

Janosch Kratz discusses the importance of medical cannabis for chronic pain diseases.

The Michael G. DeGroote Institute for Pain Research and Care seeks to improve the quality of life for those living with Chronic Pain.

We spoke to Dr Charles Shepherd about the impact of myalgic encephalomyelitis/chronic fatigue syndrome and why more needs to be done to address gaps in care and research.

Stephen Vanner, president of pHarm Therapeutics Inc., and Christoph Stein, inventor and co-founder, discuss a new class of analgesics for pain caused by tissue injury and inflammation.

Professor Patrick Stroman from the Centre for Neuroscience Studies at Queen’s University shares insights into his research on the neural basis of human pain and pain regulation, which is supported by functional magnetic resonance imaging.

There is a 2-minute corrective exercise which research proves provides relief from low back pain to 90% of those who do it, explains Dr. Hélène Bertrand, who discusses the impact of SI joints and possible pain treatments.

Study finds link between income and experience of physical pain, suggesting that a a lower income rank is linked to a higher likelihood of experiencing pain.